QCG
RCKT icon

Quadrant Capital Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Quadrant Capital Group’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,417
Closed -$69.5K – 2262
2026
Q1 		$69.5K Sell
19,417
-3,679
-16% -$14.6K ﹤0.01% 1590
2025
Q4 		$81.1K Buy
23,096
+7,056
+44% +$24.2K ﹤0.01% 1540
2025
Q3 		$52.3K Buy
+16,040
New +$50.5K ﹤0.01% 1660
2025
Q2 		– Sell
-26,825
Closed -$179K – 2304
2025
Q1 		$179K Buy
26,825
+25,590
+2,072% +$253K 0.01% 1350
2024
Q4 		$15.5K Buy
1,235
+1,076
+677% +$16.2K ﹤0.01% 1986
2024
Q3 		$2.94K Buy
159
+55
+53% +$1.13K ﹤0.01% 2431
2024
Q2 		$2.24K Hold
104
– – ﹤0.01% 2457
2024
Q1 		$2.8K Hold
104
– – ﹤0.01% 2440
2023
Q4 		$3.12K Hold
104
– – ﹤0.01% 2389
2023
Q3 		$2.13K Hold
104
– – ﹤0.01% 2373
2023
Q2 		$2.07K Hold
104
– – ﹤0.01% 2405
2023
Q1 		$1.78K Hold
104
– – ﹤0.01% 2447
2022
Q4 		$2.04K Hold
104
– – ﹤0.01% 2413
2022
Q3 		$2K Hold
104
– – ﹤0.01% 2413
2022
Q2 		$1K Buy
104
+92
+767% +$1.1K ﹤0.01% 2434
2022
Q1 		$0 Sell
12
-33
-73% -$570 ﹤0.01% 2663
2021
Q4 		$1K Sell
45
-16
-26% -$436 ﹤0.01% 2386
2021
Q3 		$2K Sell
61
-47
-44% -$1.71K ﹤0.01% 2184
2021
Q2 		$5K Buy
108
+63
+140% +$2.74K ﹤0.01% 1852
2021
Q1 		$2K Hold
45
– – ﹤0.01% 2109
2020
Q4 		$2K Hold
45
– – ﹤0.01% 1988
2020
Q3 		$1K Buy
+45
New +$1.11K ﹤0.01% 2038

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Quadrant Capital Group's RCKT Position: Q2 2026 in Review

Quadrant Capital Group sold out of Rocket Pharmaceuticals (RCKT) in Q2 2026, closing a stake of 19,417 shares — an estimated $69.5K sold.

Quadrant Capital Group first reported a position in RCKT in Q3 2020 and held it in 22 quarters. The position peaked at $179K in Q1 2025. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Quadrant Capital Group reported no remaining Rocket Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 19,417 Rocket Pharmaceuticals shares in Q2 2026, an estimated $69.5K.
  • Quadrant Capital Group first reported a position in Rocket Pharmaceuticals in Q3 2020 and held it in 22 quarters.
  • Quadrant Capital Group's Rocket Pharmaceuticals position peaked at $179K in Q1 2025.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.